FI941628A0 - A mixture to stop bleeding locally - Google Patents

A mixture to stop bleeding locally

Info

Publication number
FI941628A0
FI941628A0 FI941628A FI941628A FI941628A0 FI 941628 A0 FI941628 A0 FI 941628A0 FI 941628 A FI941628 A FI 941628A FI 941628 A FI941628 A FI 941628A FI 941628 A0 FI941628 A0 FI 941628A0
Authority
FI
Finland
Prior art keywords
locally
mixture
stop bleeding
bleeding
stop
Prior art date
Application number
FI941628A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI941628A (en
Inventor
Ulla Karin Elisabeth Hedner
Erik Oestergaard
Martin William Edvards
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI941628A0 publication Critical patent/FI941628A0/en
Publication of FI941628A publication Critical patent/FI941628A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/108—Specific proteins or polypeptides not covered by groups A61L24/102 - A61L24/106
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI941628A 1991-10-11 1994-04-08 Composition for local hemostasis FI941628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77566491A 1991-10-11 1991-10-11
PCT/DK1992/000296 WO1993006855A1 (en) 1991-10-11 1992-10-09 Hemostatic composition for local hemostasis

Publications (2)

Publication Number Publication Date
FI941628A0 true FI941628A0 (en) 1994-04-08
FI941628A FI941628A (en) 1994-06-08

Family

ID=25105103

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941628A FI941628A (en) 1991-10-11 1994-04-08 Composition for local hemostasis

Country Status (9)

Country Link
EP (1) EP0613377A1 (en)
JP (1) JPH07500095A (en)
AU (1) AU2793292A (en)
CA (1) CA2121028A1 (en)
CZ (1) CZ83194A3 (en)
FI (1) FI941628A (en)
HU (1) HUT67693A (en)
NO (1) NO941285L (en)
WO (1) WO1993006855A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012371A1 (en) * 1993-11-03 1995-05-11 Clarion Pharmaceuticals, Inc. Hemostatic patch
DE19903693A1 (en) * 1998-04-24 1999-10-28 Centeon Pharma Gmbh Protease for activation of coagulation factor VII
FR2754183A1 (en) * 1996-10-08 1998-04-10 Lefebvre Jean Marie VISCOUS HEMOSTATIC COMPOSITION, IN PARTICULAR IN THE CONDITION OF FROST
DE19710190A1 (en) * 1997-03-12 1998-09-17 Immuno Ag Activated vitamin K-dependent blood factor and method for its production
WO1998058661A1 (en) * 1997-06-23 1998-12-30 Novo Nordisk A/S Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
ATE411041T1 (en) 1999-07-14 2008-10-15 Novo Nordisk Healthcare Ag USE OF FVIIA OR A TISSUE FACTOR AGONIST TO REGULATE GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS
GB0011053D0 (en) 2000-05-09 2000-06-28 Hudson John O Medical device and use thereof
JP2004505016A (en) * 2000-05-10 2004-02-19 ノボ　ノルディスク　アクティーゼルスカブ Pharmaceutical composition comprising factor VIIa and factor XIII
US7015194B2 (en) 2000-05-10 2006-03-21 Novo Nordisk A/S Pharmaceutical composition comprising factor VIIa and anti-TFPI
EP1190724B8 (en) 2000-09-22 2006-05-03 Perlei Medical Produkte GmbH Use of antifibrinolytic agents for preparing sponges, compresses or dressings
US7291587B2 (en) 2001-11-09 2007-11-06 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and TAFI polypeptides
WO2003039579A1 (en) 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and tafi polypeptides
WO2003039581A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and tranexamic acid
WO2003039590A1 (en) * 2001-11-09 2003-05-15 Novo Nordisk Health Care Ag Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides
US7078479B2 (en) 2001-11-09 2006-07-18 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and alpha2-antiplasmin polypeptides
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
EP1446148A1 (en) * 2001-11-09 2004-08-18 Novo Nordisk A/S Pharmaceutical composition comprising a factor vii polypeptide and epsilon-aminocapronic acid
GB2409162B (en) * 2004-10-06 2005-12-14 Bhk Holding Ltd Materials,methods,and apparatus for treating a body cavity
AR048742A1 (en) * 2004-12-22 2006-05-24 Gador Sa INTRA-ORAL MEDICINES APPLICATION SYSTEM
FR2894831B1 (en) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement THROMBIN FREE BIOLOGICAL GLUE AND USE THEREOF AS MEDICAMENT.
EP2004214B1 (en) * 2006-03-16 2012-11-07 STELLARIS PHARMACEUTICALS Aps Local treatment with factor vii
GB2447012B (en) * 2007-02-21 2011-03-16 Pharmacure Health Care Ab Composition for combating epistaxis
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
DK2252335T3 (en) * 2008-03-03 2013-07-08 Omrix Biopharmaceuticals Ltd GELATIN FUNGI, INCLUDING AN ACTIVE INGREDIENT, MANUFACTURING AND USING THEREOF
RU2501556C2 (en) * 2011-10-06 2013-12-20 Владимир Лазаревич Адамян Heamostatic match
CA2865349C (en) 2012-03-06 2021-07-06 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
EP2977066A3 (en) 2012-06-12 2016-07-27 Ferrosan Medical Devices A/S Dry haemostatic composition
JP6390873B2 (en) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス Dry composition expanded under reduced pressure and syringe for holding the same
RU2678592C1 (en) 2013-12-11 2019-01-30 Ферросан Медикал Дивайсиз А/С Dry composition comprising extrusion enhancer
AU2015333206B2 (en) 2014-10-13 2019-07-11 Ferrosan Medical Devices A/S. Dry composition for use in haemostasis and wound healing
US10653837B2 (en) 2014-12-24 2020-05-19 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
EP3316930B1 (en) 2015-07-03 2019-07-31 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
BR112018004056B1 (en) * 2015-09-01 2021-06-29 Baxter International Inc HEMOSTATIC MATERIAL, METHOD FOR PRODUCING A HEMOSTATIC MATERIAL, AND KIT
BR112020021998A2 (en) 2018-05-09 2021-01-26 Ferrosan Medical Devices A/S methods for preparing a hemostatic composition and for reconstituting a dry thrombin composition, hemostatic composition, and, kit.
WO2021128050A1 (en) * 2019-12-25 2021-07-01 Guangzhou Bioseal Biotech Co., Ltd. Hemostatic paste and uses thereof
WO2024042148A1 (en) 2022-08-26 2024-02-29 Stellaris Pharmaceuticals Aps Haemorrhage inhibiting compositions and methods involving the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4382083A (en) * 1981-06-25 1983-05-03 Baxter Travenol Laboratories, Inc. Therapeutic method for treating blood-clotting defects with factor VIIa
ES2037664T3 (en) * 1985-11-26 1993-07-01 Novo Nordisk A/S COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMORRHAGIC DISORDERS.

Also Published As

Publication number Publication date
CZ83194A3 (en) 1994-11-16
HUT67693A (en) 1995-04-28
NO941285D0 (en) 1994-04-08
FI941628A (en) 1994-06-08
EP0613377A1 (en) 1994-09-07
WO1993006855A1 (en) 1993-04-15
JPH07500095A (en) 1995-01-05
NO941285L (en) 1994-06-07
HU9401008D0 (en) 1994-07-28
AU2793292A (en) 1993-05-03
CA2121028A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
FI941628A0 (en) A mixture to stop bleeding locally
DK44389D0 (en) SYNERGIC ANTIOXIDANT MIXTURE
BR9205781A (en) Composition process to produce the composition
BR9205672A (en) Gaseous composition
KR900011269A (en) How to perform multi-screen
NO933800D0 (en) Particulate detergent mixture
DE69208040D1 (en) Stapler
BR8901146A (en) PA TO HELICE CARENADA
DE69229332D1 (en) Positive working resist composition
MX9203919A (en) PROCEDURE TO PURIFY ORGANOPOLISILOXANES.
DE69209356D1 (en) Positive working resist composition
DE69223083D1 (en) Positive working resist composition
BR7002423U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO LACRE
KR920015266U (en) Fasteners
GB2256420B (en) Improvements relating to fibre-wound structures
BR7101923U (en) PROVISION PROVIDED TO ABACO
BR7100634U (en) PROVISION PROVIDED TO TECHADURA
BR9101347A (en) MACHINE TO MAKE SNACKS
BR7100729U (en) PROVISION PROVIDED TO THE TRAILER STRUCTURE
BR7101317U (en) ARRANGEMENT PROVIDED TO POCKETKNIVES
BR6900532U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO BUCKLE
BR7201288U (en) PROVISION PROVIDED TO SEMATORO
BR7100021U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO CASH-ARCHIVE
DE69214363D1 (en) Abutment button
BR7100539U (en) CONSTRUCTIVE ARRANGEMENT APPLIED TO AUTOMATIC BRICK CUTTER

Legal Events

Date Code Title Description
FD Application lapsed